James Patrick Kelly, EVP & Chief Financial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 3,313 shares at $26.31 ($87K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Seasonal sale ($87k) by EVP & Chief Financial Officer — this insider has traded VNDA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2019-03-04 | $548K | — | Filing → |
| VNDA | SELL | 2019-01-04 | $232K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |